OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
In vitro Anti-malignant Property of PCMT1 Silencing and Identification of the SNHG16/miR-195/PCMT1 Regulatory Axis in Breast Cancer Cells
Zhongji Zhang, Fengbo Li, Yan Li, et al.
Clinical Breast Cancer (2022) Vol. 23, Iss. 3, pp. 302-316
Closed Access | Times Cited: 8
Zhongji Zhang, Fengbo Li, Yan Li, et al.
Clinical Breast Cancer (2022) Vol. 23, Iss. 3, pp. 302-316
Closed Access | Times Cited: 8
Showing 8 citing articles:
MicroRNA-205-5p inhibits the growth and migration of breast cancer through targeting Wnt/β-catenin co-receptor LRP6 and interacting with lncRNAs
Sameh H. Mohamed, Mohamed M. Kamal, Ahmed Reda, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 1
Sameh H. Mohamed, Mohamed M. Kamal, Ahmed Reda, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 1
PCMT1 knockdown attenuates malignant properties by globally regulating transcriptome profiles in triple-negative breast cancer cells
Aili Saiding, Dilinuer Maimaitiyiming, Minglan Chen, et al.
PeerJ (2023) Vol. 11, pp. e16006-e16006
Open Access | Times Cited: 2
Aili Saiding, Dilinuer Maimaitiyiming, Minglan Chen, et al.
PeerJ (2023) Vol. 11, pp. e16006-e16006
Open Access | Times Cited: 2
Silencing PCMT1 enhances the sensitivity of breast cancer cells to paclitaxel through the PI3K /Akt/STMN1 pathway
Ke Zhang, Jinyou Li, Kai Li
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 6
Closed Access
Ke Zhang, Jinyou Li, Kai Li
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 6
Closed Access
PCMT1 as a prognostic marker in breast cancer
Patryk Rogaczewski, Michał Janiak, Jędrzej Borowczak, et al.
Clinical & Translational Oncology (2024)
Open Access
Patryk Rogaczewski, Michał Janiak, Jędrzej Borowczak, et al.
Clinical & Translational Oncology (2024)
Open Access
New insights of LncRNAs fingerprints in breast cancer progression: Tumorigenesis, drug resistance, and therapeutic opportunities
Bashdar Mahmud Hussen, Diyar Idris Othman, Snur Rasool Abdullah, et al.
International Journal of Biological Macromolecules (2024) Vol. 287, pp. 138589-138589
Open Access
Bashdar Mahmud Hussen, Diyar Idris Othman, Snur Rasool Abdullah, et al.
International Journal of Biological Macromolecules (2024) Vol. 287, pp. 138589-138589
Open Access
Patients with Systemic Juvenile Idiopathic Arthritis (SJIA) Show Differences in Autoantibody Signatures Based on Disease Activity
Julie Krainer, Michaela Hendling, Sandra Siebenhandl, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1392-1392
Open Access | Times Cited: 1
Julie Krainer, Michaela Hendling, Sandra Siebenhandl, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1392-1392
Open Access | Times Cited: 1
[Prognostic Value of PCMT1 Expression in Gastric Cancer and Its Regulatory Effect on Spindle Assembly Checkpoints].
Yueyue Wang, Min Zhang, Zhen Zhang, et al.
PubMed (2023) Vol. 54, Iss. 6, pp. 1167-1175
Closed Access | Times Cited: 1
Yueyue Wang, Min Zhang, Zhen Zhang, et al.
PubMed (2023) Vol. 54, Iss. 6, pp. 1167-1175
Closed Access | Times Cited: 1
LncRNA SNHG16 modulates paclitaxel resistance in breast cancer by regulating Let-7a-5p/DUSP7
Hui Zhao, Lei Wang, Yueqing Feng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Hui Zhao, Lei Wang, Yueqing Feng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
